PANAJI: Pharma firm Indoco has said it secured a strategic lead by licensing out its intellectual property to South Africa’s largest pharmaceutical company Aspen Pharmacare Ltd. The deal encompasses a number of ophthalmic products and will extend to 30 countries from emerging markets.

Indoco will offer these products for registration and supply the same from their USFDA and EU-approved manufacturing facilities, a company release said here. Aspen will market and distribute these products immediately on obtaining the regulatory approval, the release said.

The deal is expected to be significant in view of the large market-size and availability of the products in the short-term thus opening vast markets for Indoco, where the Aspen group has a strong marketing presence, it said.

Commenting on the tie-up Indoco chairman and managing director, Mr Suresh G Kare said: "The Indoco-Aspen tie-up will bolster our international foothold thereby catapulting Indoco to a level critical to be recognised as a significant international player,".